Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Outcome measures for nutritional research in HIV/AIDS.
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.
The Low Prevalence of Inclusion Body Myositis in an Outpatient Rheumatology Myositis Cohort.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Low Prevalence of Inclusion Body Myositis in an Outpatient Rheumatology Myositis Cohort.
The Low Prevalence of Inclusion Body Myositis in an Outpatient Rheumatology Myositis Cohort. Cureus. 2020 Aug 19; 12(8):e9873.
View in:
PubMed
authors with profiles
Augustine M Manadan